Journal article icon

Journal article

DNA vaccines against human immunodeficiency virus type 1.

Abstract:

Development of a vaccine against human immunodeficiency virus type 1 (HIV-1) is the main hope for controlling the acquired immunodeficiency syndrome pandemic. An ideal HIV vaccine should induce neutralizing antibodies, CD4+ helper T cells, and CD8+ cytotoxic T cells. While the induction of broadly neutralizing antibodies remains a highly challenging goal, there are a number of technologies capable of inducing potent cell-mediated responses in animal models, which are now starting to be tested...

Expand abstract
Publication status:
Published

Actions


Access Document


Authors


More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, Clinical Medicine, Experimental Medicine Division,
Role:
Author
More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, Clinical Medicine, Jenner Institute
Role:
Author
Journal:
Immunological reviews
Volume:
199
Issue:
1
Pages:
144-155
Publication date:
2004-06-05
DOI:
EISSN:
1600-065X
ISSN:
0105-2896
URN:
uuid:1a908093-fd70-4dcf-b713-bac7ba5f4d08
Source identifiers:
32771
Local pid:
pubs:32771

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP